ITNs are collaborative training programmes designed around a specific research objective. Projects typically involve a partnership (consortium) of universities, businesses, SMEs and other organisations across different European countries. The focus is on initial and doctoral training of early stage researchers (typically post-graduates). Activities will include secondments and transferable skills training in addition to individual research objectives. There are two types of ITN that are relevant to Oxford. The first, the European Training Network (ETN), requires a minimum of at least three institutions in at least three European countries. The second, the European Industrial Doctorate (EID), requires a minimum of one University and one non-academic partner from different European countries.
RISE (Research and Innovation Staff Exchange) projects are staff exchange programmes designed around a common research objective. They support short-term cross-border and cross-sector secondment and visit activity of research staff at all career levels. Projects require partnerships of universities, research institutions, and non-academic organisations both within and beyond Europe.
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. COST funds bottom-up, excellence-driven, open and inclusive networks in all areas of science and technology. Funding is for networking costs such as travel and workshops (capped according to scheme rules). Proposals for new networks are consortium based. Alternatively an organisation can apply to join an existing COST action.
More information about COST can be found on the COST website.
The Innovative Medicines Initiative (IMI) aims to improve health by speeding up the development of, and patient access to, innovative medicines. IMI works particularly in areas where there is an unmet medical or social need. It is a partnership between the European Union and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).
IMI issues a number of calls for proposals each year – most follow a two-stage application process. Funding follows the Horizon 2020 collaborative project funding model.
More information about IMI can be found on the IMI website.
The European & Developing Countries Clinical Trials Partnership (EDCTP) funds collaborative clinical research projects conducted in sub-Saharan Africa on poverty-related infectious diseases. Its aim is to accelerate development of new or improved drugs, vaccines, microbicides and diagnostics. These are used to fight against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa. The focus is on phase II and III clinical trials. Funding follows the Horizon 2020 collaborative project funding model.
The European Metrology Programme for Innovation and Research (EMPIR) is part funded by Horizon 2020. It coordinates research projects to address grand challenges, while supporting and developing the SI system of measurement units. The focus is on innovation activities to target the needs of industry and accelerate the uptake of research outputs. The programme’s capacity-building projects aim to bridge the gap between EU member states with emerging measurement systems and those with more developed capabilities.
ERA-NETs are collaborations in particular research areas between EU countries’ national funders. The European Commission provides funding for the set up and administration of each ERA-NET, which issue their own multinational collaborative calls. Funding for successful research projects is provided by the national funders participating in that particular ERA-NET – in the UK this is usually UKRI. Each ERA-NET has a different set of national members. The University of Oxford can participate only in calls issued by ERA-NETs that have UK membership.
The EIT was established in 2008 to bring together the three sides of the ‘knowledge triangle’ - higher education, research and business. The EIT’s mission is to:
Increase European sustainable growth and competitiveness
Reinforce the innovation capacity of the EU Member States, and
Create the entrepreneurs of tomorrow and prepare for the next innovative breakthroughs
The EIT funds ‘Knowledge and Innovation Communities’ (KICs) which aim to bring together major players from higher education, research and business. KICs carry out a whole range of activities, covering the entire innovation chain. These include training and education programmes, as well as research projects and business incubation activity.
KICs issue calls for proposals across their areas of activity. Each KIC operates autonomously and uses a different application and award management system.
For researchers to participate in calls issued by a KIC the University has to be a member of that KIC.
EIT Health issues its own calls using its own submission system (PLAZA). Applicants apply to be part of the programme of activities for the next calendar year. EIT Health selects proposals it wants to include in that programme to create its business plan. The costed business plan is put to the EIT with the business plans of all the other KICs. When EIT approves the plan a grant agreement is signed between the EIT and EIT Health. Project Grant Agreements are put in place for each activity within the business plan. Projects can be for one year or more than one year in length. Funding is guaranteed on an annual basis.
All projects (whether research or not) must be costed and run according to Horizon 2020 rules and records requirements.
For information about EIT Health please contact the European & International Team.